Condition 1: periorbital dark circles. Condition 2: Skin aging. Chloasma of eyelid and periocular area Atrophic disorder of skin, unspecified
Conditions
Interventions
Intervention 1: Control group 1: In one session, patients are treated with 5 cc of nanofat injection (prepared at the research center clinic) in the whole face and under the eyes. Intervention 2: Cont
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age from 18 to 65 years Patient with periorbital dark circles The patient has wrinkles
Exclusion criteria
Exclusion criteria: Active infection on face Pregnancy Breastfeeding History of cancer structural dark circles or under eye loss of fat
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Periorbital dark circles. Timepoint: Before, during the treatment and 3 months after intervention. Method of measurement: severity of under eye dark halos in comparison to the rest of the face, using Mexameter device.;The amount of wrinkles. Timepoint: Before treatment and six months after intervention. Method of measurement: Visio face. | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction rate. Timepoint: After completing the intervention. Method of measurement: comparing the severity of periorbital dark circles, before and after treatment (score from 0 - 10).;Inflammation. Timepoint: Half an hour after the end of the intervention. Method of measurement: Questionnaire and visit.;Intensity of pain. Timepoint: At the time of the intervention. Method of measurement: Questionnaire and visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem cell Research Center of Tehran University of Medical Sciences
Outcome results
None listed